Mobile

Long term study to evaluate the safety and benefit of subcutaneous RoActemra/Actemra in the treatment of Juvenile Idiopathic Arthritis patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-005212-98

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the long-term safety of subcutaneous (SC) administration of TCZ in patients with pcJIA and sJIA To describe the long-term efficacy of SC TCZ in patients with pcJIA and sJIA

Critère d'inclusion

  • Polyarticular-course juvenile idiopathic arthritis (pJIA); Systemic juvenile idiopathic arthritis (sJIA)

Liens